Cargando…

Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity

Estrogen Receptor-β (ERβ) has been implicated in many cancers. In prostate and breast cancer its function is controversial, but genetic studies implicate a role in cancer progression. Much of the confusion around ERβ stems from antibodies that are inadequately validated, yet have become standard too...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nelson, Adam W., Groen, Arnoud J., Miller, Jodi L., Warren, Anne Y., Holmes, Kelly A., Tarulli, Gerard A., Tilley, Wayne D., Katzenellenbogen, Benita S., Hawse, John R., Gnanapragasam, Vincent J., Carroll, Jason S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	North Holland Publishing 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228587/ https://www.ncbi.nlm.nih.gov/pubmed/27889472 http://dx.doi.org/10.1016/j.mce.2016.11.016

Ejemplares similares

Corrigendum to “Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity” [Mol. Cell Endocrinol. 440 (2016) 138–150]
por: Nelson, A.W., et al.
Publicado: (2017)

Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta - regulation by selective estrogen receptor modulators and importance in breast cancer
por: S Katzenellenbogen, Benita, et al.
Publicado: (2000)

Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
por: Madak-Erdogan, Zeynep, et al.
Publicado: (2013)

Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
por: Madak‐Erdogan, Zeynep, et al.
Publicado: (2017)

Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen
por: Wu, Xianglin, et al.
Publicado: (2011)

Transcriptomic analysis identifies gene networks regulated by estrogen receptor α (ERα) and ERβ that control distinct effects of different botanical estrogens
por: Gong, Ping, et al.
Publicado: (2014)

Macrophage-Elicited Loss of Estrogen Receptor Alpha in Breast Cancer Cells via Involvement of MAPK and c-Jun at the ESR1 Genomic Locus
por: Stossi, Fabio, et al.
Publicado: (2011)

Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets
por: Zuo, Qianying, et al.
Publicado: (2021)

Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer
por: Singhal, Hari, et al.
Publicado: (2016)

OR11-01 A New Model for Estrogen Receptor-alpha Antagonist Mechanism of Action
por: Nwachukwu, Jerome C, et al.
Publicado: (2023)

SUN-LB135 Estrogen Receptor Beta Inhibits NFkB Signaling to Inhibit Triple Negative Breast Cancer
por: Aspros, Kirsten, et al.
Publicado: (2020)

The structural pervasiveness of estrogenic activity.
por: Katzenellenbogen, J A
Publicado: (1995)

Estrogen Receptor Beta-Mediated Modulation of Lung Cancer Cell Proliferation by 27-Hydroxycholesterol
por: Hiramitsu, Shiro, et al.
Publicado: (2018)

Stringing along the estrogen receptor to engage with DNA
por: Katzenellenbogen, John A.
Publicado: (2023)

Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast Cancer
por: Mayne, Christopher G., et al.
Publicado: (2021)

Full Antagonism of the Estrogen Receptor without a Prototypical Ligand Side Chain
por: Srinivasan, Sathish, et al.
Publicado: (2016)

Respective role of membrane and nuclear estrogen receptor (ER) α in the mandible of growing mice: Implications for ERα modulation
por: Vinel, Alexia, et al.
Publicado: (2018)

Progesterone receptor modulates estrogen receptor-α action in breast cancer
por: Mohammed, Hisham, et al.
Publicado: (2015)

OR09-2 Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets
por: Zuo, Qianying, et al.
Publicado: (2019)

Highly Selective Salicylketoxime-Based Estrogen Receptor β Agonists Display Antiproliferative Activities in a Glioma Model
por: Paterni, Ilaria, et al.
Publicado: (2015)

The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells
por: Bergamaschi, Anna, et al.
Publicado: (2014)

Predominant Role of Nuclear Versus Membrane Estrogen Receptor α in Arterial Protection: Implications for Estrogen Receptor α Modulation in Cardiovascular Prevention/Safety
por: Guivarc'h, Emmanuel, et al.
Publicado: (2018)

Disruption of estrogen receptor beta’s DNA binding domain impairs its tumor suppressive effects in triple negative breast cancer
por: Aspros, Kirsten G. M., et al.
Publicado: (2023)

Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer
por: Katzenellenbogen, Benita S., et al.
Publicado: (2023)

Bicyclobutanes: from curiosities to versatile reagents and covalent warheads
por: Kelly, Christopher B., et al.
Publicado: (2022)

Tamoxifen down-regulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance
por: Bergamaschi, Anna, et al.
Publicado: (2011)

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer
por: Aspros, Kirsten G. M., et al.
Publicado: (2022)

Selective C-H trifluoromethoxylation of (hetero)arenes as limiting reagent
por: Deng, Zhijie, et al.
Publicado: (2020)

TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions
por: Broome, Rebecca, et al.
Publicado: (2021)

OR12-07 Full Antagonism of Breast Cancer Cell Proliferation Can Result from Many Ligand-Induced Conformational Distortions of the Estrogen Receptor Ligand Binding Domain
por: Nwachukwu, Jerome, et al.
Publicado: (2020)

The Activation Function-1 of Estrogen Receptor Alpha Prevents Arterial Neointima Development Through a Direct Effect on Smooth Muscle Cells
por: Smirnova, Natalia F., et al.
Publicado: (2015)

Estrogen rescues heart failure through estrogen receptor Beta activation
por: Iorga, Andrea, et al.
Publicado: (2018)

PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging
por: Katzenellenbogen, John A.
Publicado: (2020)

Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3ζ, FOXM1, and a gene signature associated with mitosis
por: Bergamaschi, Anna, et al.
Publicado: (2011)

Transcription Regulation and Genome Rewiring Governing Sensitivity and Resistance to FOXM1 Inhibition in Breast Cancer
por: Ziegler, Yvonne, et al.
Publicado: (2021)

Divinylpyrimidine reagents generate antibody–drug conjugates with excellent in vivo efficacy and tolerability
por: Walsh, Stephen J., et al.
Publicado: (2022)

Poly(Beta-Amino Ester)s as High-Yield Transfection Reagents for Recombinant Protein Production
por: Luly, Kathryn M, et al.
Publicado: (2022)

Reagent Strips as an Aid to Diagnosis of Neonatal Meningitis in a Resource-limited Setting
por: Burgoine, Kathy, et al.
Publicado: (2018)

Loss of WISP2/CCN5 in Estrogen-Dependent MCF7 Human Breast Cancer Cells Promotes a Stem-Like Cell Phenotype
por: Ferrand, Nathalie, et al.
Publicado: (2014)

Metagenomic Identification of Viral Sequences in Laboratory Reagents
por: Porter, Ashleigh F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nuh4e425g73ge4g1om35u8m3le